lerodalcibep

Trials studying lerodalcibep

• phase3Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FHenrolling by invitationn=150
• phase3A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemiarecruitingn=210
• phase3Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patientscompletedn=166
• phase3Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reductionenrolling by invitationn=2,000
• phase3Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reductionunknownn=900
• phase3Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reductioncompletedn=478
• phase3Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reductionunknownn=900